Vira Shield 6 + VL5HB (Canada)This page contains information on Vira Shield 6 + VL5HB for veterinary use.
The information provided typically includes the following:
- Vira Shield 6 + VL5HB Indications
- Warnings and cautions for Vira Shield 6 + VL5HB
- Direction and dosage information for Vira Shield 6 + VL5HB
Vira Shield 6 + VL5HBThis treatment applies to the following species:
Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine
Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
For Use in Animals Only
Vira Shield 6 + VL5HB Indications
For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.
ADJUVANT: Xtend® SP
Directions For Use
Shake well before using. Administer 5 ml subcutaneously 2-4 weeks
prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should
be administered subcutaneously (under the skin) in the neck. Revaccinate with Vira Shield® 6 + L5HB in 4-5 weeks. Revaccinate annually or as recommended by your veterinarian.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
U.S. Vet. License No. 303
Novartis Animal Health US, Inc.
© 2012 Novartis; Registered trademarks of Novartis AG, used under license.
Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9
NAC No.: 1231108.1
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Elanco Canada Limited Customer Service Telephone:||800-387-6325|
|Elanco Canada Limited Customer Service Fax:||800-827-5782|
|Every effort has been made to ensure the accuracy of the Vira Shield 6 + VL5HB information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10